Stockreport

BioAffinity Shares Rise 44% on Lung Cancer Test Study Data [MarketWatch]

bioAffinity Technologies, Inc.  (BIAF) 
PDF clinical trial studying CyPath Lung, its non-invasive early-stage lung cancer diagnostic test. The San Antonio, Texas, company said the CyPath Lung trial showed 92% se [Read more]